$13.46 +0.31 (%) Osiris Therapeutics Inc - NASDAQ

Sep. 19, 2014 | 04:00 PM

Partner Headlines

  1. Osiris Stem Cells To Compliment Mannkind's Afrezza In Disrupting Diabetes Market

    GuruFocus | Jul. 29, 2014 | 17:50PM EST
  2. Journal Publishes Grafix Clinical Study for Chronic Wounds

    Benzinga | Dec. 18, 2013 | 08:37AM EST
  3. Osiris Therapeutics Reports CMS Decides to Package Reimbursement for Products Used in Advanced Wound Care with the Related Surgical Procedure into Two-Tier System

    Benzinga | Nov. 29, 2013 | 11:33AM EST
  4. Osiris Therapeutics Says Trial on Grafix Met All Primary, Secondary Endpoints

    Benzinga | Nov. 19, 2013 | 14:32PM EST
  5. Market Wrap for Monday, October 21: Dow Closes Down, S&P and Nasdaq Close Up

    Benzinga | Oct. 21, 2013 | 16:15PM EST
  6. Mid-Afternoon Market Update: JC Penney Falls on Massive Volume Following Imperial Capital Price Target

    Benzinga | Oct. 21, 2013 | 15:29PM EST
  7. Osiris Legal Team Responds, Says Reviewing All of Legal-Regulatory Options, Calls TheStreet Story 'Misleading'

    Benzinga | Oct. 21, 2013 | 15:01PM EST
  8. Mid-Day Market Update: Hasbro Surges On Upbeat Earnings; Gannett Shares Tumble

    Benzinga | Oct. 21, 2013 | 12:51PM EST
  9. Mesoblast Acquires Culture Expanded Stem Cell Therapeutic Business from Osiris

    Benzinga | Oct. 10, 2013 | 21:41PM EST
  10. Market Wrap For October 2: Dollar Moves As Shutdown Continues

    Benzinga | Oct. 2, 2013 | 17:38PM EST
  11. Mid-Afternoon Market Update: Tesla Drops on Baird Downgrade and YouTube Video

    Benzinga | Oct. 2, 2013 | 15:40PM EST
  12. UPDATE: Piper Jaffray Upgrades Osiris Therapeutics, Pull-Back Offers Attractive Entry Point

    Benzinga | Oct. 2, 2013 | 09:10AM EST
  13. Benzinga's Top Pre-Market Gainers

    Benzinga | Aug. 14, 2013 | 08:07AM EST
  14. Mid-Afternoon Market Update: Apple Rises Sharply On Icahn Stake, NASDAQ Pulled Upward

    Benzinga | Aug. 13, 2013 | 15:43PM EST
  15. UPDATE: Piper Jaffray Downgrades Osiris Therapeutics on DFU Data

    Benzinga | Aug. 13, 2013 | 12:58PM EST
  16. Mid-Day Market Update: US Stocks Edge Higher; Valspar Shares Decline On Downbeat Results

    Benzinga | Aug. 13, 2013 | 12:52PM EST
  17. Mid-Morning Market Update: Markets Drop, Yum China Same-Store Sales Down 13%

    Benzinga | Aug. 13, 2013 | 10:42AM EST
  18. Benzinga's Volume Movers

    Benzinga | Aug. 13, 2013 | 10:29AM EST
  19. Stocks Hitting 52-Week Highs

    Benzinga | Aug. 13, 2013 | 10:22AM EST
  20. Morning Market Movers

    Benzinga | Aug. 13, 2013 | 09:51AM EST
  21. Osiris Reports Strong Efficacy for Grafix to Treat Diabetic Foot Ulcers

    Benzinga | Aug. 13, 2013 | 08:03AM EST
  22. Osiris Therapeutics to Hold Call on Grafix Trial Aug. 13th at 9AM EDT

    Benzinga | Aug. 12, 2013 | 16:35PM EST
  23. Earnings Scheduled For August 5, 2013

    Benzinga | Aug. 5, 2013 | 04:30AM EST
  24. Cell Therapy Might Be Poised For A Comeback

    IBD | Dec. 21, 2012 | 07:18AM EST
  25. Osiris Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 9, 2012 | 03:04AM EST
  26. Osiris Therapeutics Regains Worldwide Rights to Prochymal and Chondrogen

    Benzinga | Sep. 28, 2012 | 00:07AM EST
  27. Chicago Bridge & Iron Company N.V, Mercadolibre Among Stocks Down on Above-average Volume Monday

    FoxBusiness | Jul. 30, 2012 | 06:32AM EST
  28. These Are Four of the Hottest Biotechs in the Market Right Now

    Benzinga | Jul. 5, 2012 | 07:19AM EST
  29. Prochymal Significantly Reduces Hypertrophy, Arrhythmia and Progression to Heart Failure in Patients Suffering a Heart Attack

    Benzinga | Jul. 2, 2012 | 02:20AM EST
  30. Health Care Sector Wrap

    FoxBusiness | Jun. 26, 2012 | 10:49AM EST
  31. SBA Communications Corporation, The Ryland Group Among Stocks Hitting 52-Week Highs Tuesday

    FoxBusiness | Jun. 26, 2012 | 10:32AM EST
  32. Arena Pharmaceuticals, Merck &, Other Stocks Hit 52-Week Highs Thursday

    FoxBusiness | Jun. 21, 2012 | 06:33AM EST
  33. 'Biological Legos' Could Become a Blockbuster Innovation for Osiris Therapeutics

    GuruFocus | Jun. 20, 2012 | 06:28AM EST
  34. Osiris Receives Medicare Reimbursement Codes for Grafix

    Benzinga | May. 29, 2012 | 11:11AM EST
  35. World's First Approved Stem Cell Drug; Osiris Receives Marketing Clearance from Health Canada for Prochymal

    Benzinga | May. 17, 2012 | 10:36AM EST
  36. Earnings Scheduled For May 11

    Benzinga | May. 10, 2012 | 21:14PM EST
  37. Earnings Scheduled For March 9

    Benzinga | Mar. 8, 2012 | 21:47PM EST
Trading Center